We found that rs3818292 AA, rs3758391 CT, and rs7895833 AA and AG carriers had higher SIRT1 levels in the control group than the MS group (0.239 (2.377) vs. 1.245 (0.045); p = 0.001, 0.304 (2.770) vs. 0.089 (0.037); p < 0.001, 1.813 (2.812) vs. 0.094 (0.054); p = 0.002 and 1.872 (2.763) vs.0.089 (0.028); p = 0.004, respectively). This evidence concerns the gene SIRT1 and myeloid sarcoma.